X0306 4 2019-01-29 0000879682 VIVEVE MEDICAL, INC. VIVE 0001633167 Atkinson James G. 345 INVERNESS DR. SOUTH, BUILDING B SUITE 250 ENGLEWOOD CO 80112 1 CBO & President Common Stock 2019-01-29 4 A 0 42420 0 A 53945 D Common Stock 621237 I By IRA Common Stock 285599 I By Trust Common Stock 3825 I By Custodian for Child The reporting person is a participant in the Issuer's Amended and Restated 2013 Stock Option and Incentive Plan (the "Plan") and received a restricted stock award of 42,420 shares of common stock on January 29, 2019 (the "Grant Date"). The restricted stock award shall vest in full upon the FDA approval of the Viveve System for improvement of sexual function or stress urinary incontinence (SUI) in the United States. Shares directly beneficially owned by an individual retirement account created for the benefit of the reporting person (the "IRA"). The reporting person is the beneficiary of the IRA. Shares directly beneficially owned by Atkinson Family Revocable Trust Dated 08/26/2013 (the "Trust"). The reporting person a trustee and a co-beneficiary of the Trust. Shares purchased pursuant to a Rule 10b5-1 trading plan adopted by the reporting person as custodian for a minor child. /s/ James G. Atkinson 2019-02-08